Drug intelligence / Profile preview

GC311

Development stage
Phase 1
Lead developer
GeneCradle
Modality
AAV Vectors → Viral Vectors → Gene Addition/Replacement → Gene Therapies
Administration
Intracerebroventricular, Intravenous
01

Overview

GC311 is an adeno-associated virus (AAV) gene therapy designed to treat X-linked adrenoleukodystrophy (X-ALD), a rare genetic disorder caused by mutations in the *ABCD1* gene. The therapy utilizes an AAV vector to deliver a functional copy of the *ABCD1* gene, which encodes the adrenoleukodystrophy protein (ALDP). ALDP is essential for the transport of very-long-chain fatty acids (VLCFAs) into peroxisomes for degradation; its deficiency leads to VLCFA accumulation, causing progressive demyelination in the central nervous system and adrenal insufficiency. Developed by GeneCradle, GC311 aims to restore ALDP function and halt disease progression. It is currently in Phase 1/2 clinical development for cerebral X-linked adrenoleukodystrophy (CALD).

Other names
AAV-ABCD1 gene therapyAAV-ABCD-1 gene therapyAAV-ABCD 1 gene therapyGeneCradle X-ALD program
02

Targets

ABCD1

Beyond the preview

Go deeper on GC311.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on GC311.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call